Publications
Show: AllPeer ReviewedNon Peer Reviewed
16 non peer reviewed publications from 2018
McDonald AG and Davey GP, 'On/Off Switching During The Synthesis Of Complex Sugars', Science Trends, 2018, -
David K Finlay, What fuels Natural Killer cells against Cancer, Trinity Week Symposium , Exam Hall, TCD, 2018
David K Finlay, What fuels NK cells to destroy tumours?, Trinity Biomedical Frontiers Series, Trinity Biomedical Sciences Institute, 2018
Magnano, S., O'Sullivan, J. and Zisterer, D.M., Role of Autophagy in Chemoresistance in Oral Squamous Cell Carcinoma, International Association for Dental Research, London, England, 25 July , 2018
Creagh, E.M., Contribution of Inflammatory caspases to IBD & CRC, INITIative Network meeting, Dublin, Ireland, 23rd November 2018, 2018
Flis, E and Creagh, E.M., Role of TLR2 in Oesophageal Adenocarcinoma Progression, Training in Cancer Mechanisms & Therapeutics Meeting, Queens University, Belfast, 16th April 2018, 2018
David Finlay, What fuels Natural killer cell anti-tumour responses, Centre d'Etude des Pathologies Respiratoires (CEPR) -Institute Seminar, Tours, France, 29th May, 2018, Centre d'Etude des Pathologies Respiratoires (CEPR)
David Finlay, cMyc and Srebp drive glucose fueled Natural Killer responses, Translational Immunometabolism', Cell Press Sympsium, Basel, Switzerland, 24th June, 2018
David Finlay, Fueling Robust Anti-Tumor NK Cell Responses , Discovery on Target Conference; NK cell based Cancer Immunotherapies, Boston, 26 September, 2018
Coyle R, O'Sullivan M. & Zisterer DM, Inhibitor of Apoptosis Proteins as Targets for the Treatment of Malignant Rhabdoid Tumor, Irish Association Cancer Research, Crowne Plaza Hotel, Santry, Dublin, 22nd February 2018, 2018
Coyle R, O'Sullivan M. & Zisterer DM, Inhibitor of Apoptosis Proteins as Targets for the Treatment of Malignant Rhabdoid Tumor, European Association for Cancer Research, Amsterdam Netherlands, 1 to 3 february 2018, 2018
Amet R., Previtali V., Browne P.V., Rozas I., McElligott A.M. & Zisterer D.M. , Novel anti-cancer therapeutics for multiple myeloma which target the STAT3 signalling pathway , European Association for Cancer Research, Amsterdam Netherlands, 1 to 3 february 2018, 2018
Amet R, Rozas I, McElligott AM, Browne P and Zisterer DM, Novel Anti-Cancer Therapeutics for Multiple Myeloma that target the STAT3 signalling pathway, Irish Association Cancer Research, Crowne Plaza Hotel, Santry, Dublin, 22nd February 2018, 2018
David Finlay, Metabolic regulation of Immune responses., Institute Seminar Series, University of Lausanne, 21st November, 2018, Ping-Chih Ho
David Finlay, What fuels Natural Killer Cell anti-tumour responses., Institute Seminar Series, University of Dundee, 28th Feburary, 2018
David Finlay, Metabolic regulation of NK cell anti-tumour responses, Natural Killer Cell Symposium 2018 - of the German Society for Immunology , Hamburg, Germany, 10th September, 2018, Keynote Speaker